FTB Advisors »

Celldex Therapeutics shares owned by FTB Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by FTB Advisors from 13F filings

Historical chart of FTB Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by FTB Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by FTB Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 333 41.97
2023-12-31 $13k 333 39.66
2023-09-30 $9.2k 333 27.52
2023-06-30 $11k 333 33.93
2023-03-31 $12k 333 35.98
2022-12-31 $15k 333 44.57
2022-09-30 $9.0k 333 27.03
2022-06-30 $9.0k 333 27.03
2022-03-31 $11k 333 33.03
2021-12-31 $13k 333 39.04
2021-09-30 $18k 333 54.05